Zurcher Kantonalbank (Zurich Cantonalbank) Argenx Se Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$342.17 - $402.31 $5,132 - $6,034	-15 Reduced 17.86%	69 $26,000
Q3 2022 Nov 09, 2022	SELL	$343.2 - $395.75 $1.45 Million - $1.67 Million	-4,213 Reduced 98.05%	84 $30,000
Q2 2022 Aug 09, 2022	SELL	$269.58 - $378.88 $1,887 - $2,652	-7 Reduced 0.16%	4,297 $1.63 Million
Q1 2022 Apr 21, 2022	BUY	$254.45 - $351.06 $23,154 - $31,946	91 Added 2.16%	4,304 $1.36 Million
Q2 2021 Jul 30, 2021	BUY	$257.11 - $319.92 $45,251 - $56,305	176 Added 4.36%	4,213 $1.27 Million
Q4 2020 Jan 28, 2021	BUY	$248.13 - $308.36 $185,104 - $230,036	746 Added 22.67%	4,037 $1.19 Million
Q4 2019 Jan 21, 2020	BUY	$106.59 - $164.21 $350,787 - $540,415	3,291 New	3,291 $528,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

Price T Rowe Associates Inc Baltimore, MD

5.82M
Shares

$3.67 Billion
0.36% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.51M
Shares

$2.21 Billion
2.99% of portfolio
Janus Henderson Group PLC London, X0

2.48M
Shares

$1.56 Billion
0.72% of portfolio
Capital World Investors Los Angeles, CA

1.7M
Shares

$1.07 Billion
0.15% of portfolio
Avoro Capital Advisors LLC New York, NY

1.24M
Shares

$780 Million
10.11% of portfolio

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.9B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account